Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M800241-JLR200 on June 25, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M800241-JLR200v1
49/11/2390    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mulya, A.
Right arrow Articles by Parks, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mulya, A.
Right arrow Articles by Parks, J. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 49, 2390-2401, November 2008
Copyright © 2008 by American Society for Biochemistry and Molecular Biology

Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL*,boxs

Anny Mulya1,*, Ji-Young Lee2,*, Abraham K. Gebre*, Elena Y. Boudyguina*, Soon-Kyu Chung*, Thomas L. Smith{dagger}, Perry L. Colvin§, Xian-Cheng Jiang** and John S. Parks3,*

* Department of Pathology, Wake Forest University Health Sciences, Winston-Salem, NC
{dagger} Department of Orthopaedic Surgery, Wake Forest University Health Sciences, Winston-Salem, NC
§ Division of Gerontology, University of Maryland School of Medicine, and Department of Veterans Affairs and Veterans Affairs Medical Center Baltimore, Geriatric Research, Education and Clinical Center, Baltimore, MD
** Department of Anatomy and Cell Biology, State University of New York, Downstate Medical Center, Brooklyn, NY
1 Present address of A. Mulya: Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195.
2 Present address of J-Y. Lee: Department of Nutrition and Health Sciences, University of Nebraska, Lincoln, NE 68583.

* This work was supported by National Institutes of Health Grants HL-049373 (J.S.P.), HL-054176 (J.S.P.), and AT027820 (J.S.P.), and an American Heart Association Mid-Atlantic Affiliate Pre-doctoral Fellowship 0515420U (A.M.).

boxs The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of a figure.

Published, JLR Papers in Press, June 25, 2008.

3 To whom correspondence should be addressed. e-mail: jparks{at}wfubmc.edu

We investigated the in vivo metabolic fate of pre-β HDL particles in human apolipoprotein A-I transgenic (hA-I Tg) mice. Pre-β HDL tracers were assembled by incubation of [125I]tyramine cellobiose-labeled apolipoprotein A-I (apoA-I) with HEK293 cells expressing ABCA1. Radiolabeled pre-β HDLs of increasing size (pre-β1, -2, -3, and -4 HDLs) were isolated by fast-protein liquid chromatography and injected into hA-I Tg-recipient mice, after which plasma decay, in vivo remodeling, and tissue uptake were monitored. Pre-β2, -3, and -4 had similar plasma die-away rates, whereas pre-β1 HDL was removed 7-fold more rapidly. Radiolabel recovered in liver and kidney 24 h after tracer injection suggested increased (P < 0.001) liver and decreased kidney catabolism as pre-β HDL size increased. In plasma, pre-β1 and -2 were rapidly (<5 min) remodeled into larger HDLs, whereas pre-β3 and -4 were remodeled into smaller HDLs. Pre-β HDLs were similarly remodeled in vitro with control or LCAT-immunodepleted plasma, but not when incubated with phospholipid transfer protein knockout plasma. Our results suggest that initial interaction of apoA-I with ABCA1 imparts a unique conformation that partially determines the in vivo metabolic fate of apoA-I, resulting in increased liver and decreased kidney catabolism as pre-β HDL particle size increases.

Supplementary key words Apolipoprotein A-I • phospholipid transfer protein • lecithin:cholesterol acyltransferase • in vivo catabolism • high density lipoproteins • ABCA1 transporter

Abbreviations: ABCA1, ATP binding cassette transporter A1; apoA-I, apolipoprotein A-I; hA-I Tg, human apolipoprotein A-I transgenic; CE, cholesteryl ester; FCR, fractional catabolic rate; FPLC, fast-protein liquid chromatography; MPM, mouse peritoneal macrophage; NDGGE, nondenaturing gradient gel electrophoresis; PL, phospholipid; PLTP, phospholipid transfer protein; RCT, reverse cholesterol transport; SR-BI, scavenger receptor class B type I; TC, tyramine cellobiose; TG, triglyceride


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement